At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
No intervention, observational study onlyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Development of a Novel Human In Vitro Sarcoidosis Model
In Brief
An observational study evaluating No intervention, observational study only for Sarcoidosis. Completed, enrolled 60 participants across 1 site.
Detailed Summary
There is currently no experimental model that accurately represents sarcoidosis. The lack of a useful research model significantly slows progress towards developing new treatments for sarcoidosis. The investigators plan to develop a new model for sarcoidosis research and will test the model to see if it helps us understand how sarcoidosis develops and if it is useful for testing new treatments.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSarcoidosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2012
First PostedMay 2013
Primary CompletionFeb 2017
TodayJul 2026
First PostedMay 20, 2013
Enrollment StartDec 19, 2012
Primary CompletionFeb 2, 2017
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 13.1 years ago
Interventions
No intervention, observational study onlyother
No intervention. We are collecting blood for an ex vivo study